Long-term efficacy and safety of peginterferon in the treatment of children with HBeAg-positive chronic hepatitis B

Journal of Viral Hepatitis
Yunhua LiuJia Wei

Abstract

Achieving 'clinical cure' in children with chronic hepatitis B (CHB) with safe and effective antiviral treatment is an unmet medical need. Peginterferon (PegIFN) has higher hepatitis B s antigen (HBsAg) clearance than nucleoside analogs (NUC). Currently, studies on interferon (IFN) in the treatment of Chinese children with CHB are relatively rare. This study aimed to further explore the efficacy of PegIFNα-2a as an antiviral treatment in Chinese children and analyse the long-term follow-up after drug discontinuation. We enrolled 118 patients with CHB (2-16 years old, 79 cases are males) treated with PegIFNα-2a by the author in the Third People's Hospital of Kunming City from February 2009 to February 2015. The course of treatment was 52 weeks, with a follow-up period of 104 weeks. All the patients completed at least 1 dose, of which 104 completed at least 36 weeks of treatment and 104 weeks of follow-up. During treatment and follow-up, indicators such as alanine aminotransferase (ALT), hepatitis B virus (HBV) DNA and HBV serological markers were monitored, and the efficacy and safety of PegIFNα-2a in the treatment of CHB patients were observed. Hepatitis B e antigen (HBeAg) clearance and seroconversion rates were 53.8% and 49%,...Continue Reading

References

Jul 1, 2005·The New England Journal of Medicine·George K K LauUNKNOWN Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group
Oct 27, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Regino P González-PeraltaUNKNOWN International Pediatric Hepatitis C Therapy Group
Nov 22, 2005·Journal of Medical Virology·Jye-Bin LinWen-Kang Chen
May 1, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karen F MurrayJacek Mizerski
Dec 20, 2014·Medical Microbiology and Immunology·Wolfram H Gerlich
Jul 15, 2015·World Journal of Gastroenterology : WJG·Peng HuangZhi-Hang Peng
Aug 1, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maureen M JonasPeter Ackerman
Apr 22, 2017·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, UNKNOWN European Association for the Study of the Liver
Feb 7, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Norah A TerraultJohn B Wong
Apr 25, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stefan WirthCynthia Wat

❮ Previous
Next ❯

Citations

Oct 23, 2020·Expert Opinion on Pharmacotherapy·Haruki KomatsuTomoo Fujisawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.